s6y

Marker Therapeutics, Inc.

Ticker
MRKR
CIK
1094038
Industry
Pharmaceutical Preparations
Formerly
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM

Financials 131

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 131 financials filings

News 213

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 213 news filings

Ownership 307

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 307 ownership filings

Prospectus 52

  1. 424B7 Prospectus filed pursuant to Rule 424(b)(7)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-3 Registration statement for specified transactions by certain issuers
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-3 Registration statement for specified transactions by certain issuers
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 52 prospectus filings

Proxies 39

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 39 proxies filings

Other 164

  1. ARS Annual report to security holders
  2. SCHEDULE 13D/A
  3. SCHEDULE 13G/A
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D/A
  7. SCHEDULE 13G/A
  8. ARS Annual report to security holders
  9. SCHEDULE 13G
  10. SCHEDULE 13G

All 164 other filings